Luza, Mirrabel .
HRN: 26-20-40 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2024
CEFUROXIME 500MG (TAB)
11/13/2024
11/20/2024
PO
500mg
BID
Thickly Msaf
Waiting Final Action
11/13/2024
METRONIDAZOLE 500MG (TAB)
11/13/2024
11/20/2024
PO
500mg
TID
Thickly Msaf
Waiting Final Action